Congressional Briefing

The Congressional Personalized Medicine Caucus and the Personalized Medicine Coalition co-organized a Congressional briefing on February 26, 2020, titled "Technologies Advancing the Future of Personalized Medicine."

The Congressional Personalized Medicine Caucus and the Personalized Medicine Coalition co-organized a virtual Congressional briefing on June 30, 2020, titled "The Personalized Medicine Community's Response to COVID-19."

The Congressional Personalized Medicine Caucus and the Personalized Medicine Coalition co-organized a virtual Congressional briefing on April 28, 2022, titled "Promoting Innovation and Delivery of Cell and Gene Therapies."

At the United States Capitol on December 5, the co-chairs of the Congressional Personalized Medicine Caucus organized a briefing in cooperation with the Personalized Medicine Coalition to help educate their colleagues in the House and Senate about the importance of adopting public policies designed to alleviate educational, reimbursement, and clinical adoption challenges that make it difficult for clinicians to take full advantage of emerging opportunities in personalized medicine. The briefing featured remarks from leaders in academia, patient advocacy, and the diagnostics industry.

On July 20, 2023, PMC and the Congressional Personalized Medicine Caucus co-hosted an educational briefing for Congressional staffers titled "Personalized Medicine and Mental Health." The briefing explored the burden of mental illness in the United States, the growing body of evidence supporting the value of pharmacogenetic-based testing in informing the treatment of mental health disorders, and what Congress can do to help expand patient access to improved diagnostic and treatment options.

On March 20, 2024, PMC, the Congressional Personalized Medicine Caucus, and the Congressional Kidney Caucus co-hosted an educational briefing for Congressional staffers titled "Personalized Medicine and Kidney Care." The briefing examined how personalized medicine is benefiting kidney transplant patients now. It also highlighted key actions the research community is taking to improve the diagnosis and treatment of kidney disease through personalized medicine.

On December 12, 2024, PMC and the Congressional Personalized Medicine Caucus co-hosted an educational briefing for Congressional staffers titled "Personalized Medicine and Cardiology." The briefing examined how advances in personalized medicine can improve the diagnosis and treatment of cardiovascular diseases through the use of genetic information, machine learning and artificial intelligence, and targeted therapy. It also explored public policies that can best support this efficient and precise approach to patient care.